Company profile EVGN

Evogene Ltd
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 22:34:43.

After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0.
Evogene expected interest is significantly lower compared to previous quarter (-73.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201925
70
180.0% QoQ
43
-38.6% QoQ
116
169.8% QoQ
2020 31
24.0% YoY -73.3% QoQ
78
11.4% YoY 151.6% QoQ
238
453.5% YoY 205.1% QoQ
271
133.6% YoY 13.9% QoQ
2021 502
1519.4% YoY 85.2% QoQ
124
59.0% YoY -75.3% QoQ
142
-40.3% YoY 14.5% QoQ
168
-38.0% YoY 18.3% QoQ
2022 70
-86.1% YoY -58.3% QoQ
83
-33.1% YoY 18.6% QoQ
94
-33.8% YoY 13.3% QoQ
61
-63.7% YoY -35.1% QoQ
2023 37
-47.1% YoY -39.3% QoQ
73
-12.0% YoY 97.3% QoQ
43
-54.3% YoY -41.1% QoQ
190
211.5% YoY 341.9% QoQ
2024 22
-40.5% YoY -88.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Evogene search interestLast update: February 08 2024 22:34:42.
Correlation coefficient between keyword and revenue is -0.65
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 22:34:43.

The average 5 years interest of Evogene was 9.51 per week.
The last year interest of Evogene compared to the last 5 years has changed by -31.44%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 18.98%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene biology to provide analysis

Correlation between past revenue and Evogene biology search interest

There is not enough data for Evogene biology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene biology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene seed traits to provide analysis

Correlation between past revenue and Evogene seed traits search interest

There is not enough data for Evogene seed traits to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene seed traits to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene agricultural products to provide analysis

Correlation between past revenue and Evogene agricultural products search interest

There is not enough data for Evogene agricultural products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene agricultural products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene human microbiome to provide analysis

Correlation between past revenue and Evogene human microbiome search interest

There is not enough data for Evogene human microbiome to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene human microbiome to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene industrial applications to provide analysis

Correlation between past revenue and Evogene industrial applications search interest

There is not enough data for Evogene industrial applications to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene industrial applications to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene medical cannabis products to provide analysis

Correlation between past revenue and Evogene medical cannabis products search interest

There is not enough data for Evogene medical cannabis products to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene medical cannabis products to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene collaborations to provide analysis

Correlation between past revenue and Evogene collaborations search interest

There is not enough data for Evogene collaborations to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene collaborations to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evogene -stock -company to provide analysis

Correlation between past revenue and Evogene -stock -company search interest

There is not enough data for Evogene -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evogene -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EVGN
Earnings date: 2024-03-07 After close
Company name: Evogene Ltd
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T08:00:00-04:00

PR Newswire
Evogene to Present at the 24th Schrödinger European User Group Meeting

2026-05-07T08:00:00-04:00

PR Newswire
Evogene Schedules First Quarter 2026 Financial Results Release

2026-04-02T16:01:00-04:00

PR Newswire
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

2026-03-09T09:00:00-04:00

PR Newswire
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

2026-03-05T07:00:00-05:00

PR Newswire
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

2026-02-25T08:00:00-05:00

PR Newswire
Evogene Releases CEO Letter to Shareholders

2026-02-19T08:00:00-05:00

PR Newswire
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

2026-02-17T08:00:00-05:00

PR Newswire
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

2026-02-11T08:00:00-05:00

PR Newswire
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

2026-02-10T13:20:00-05:00

PR Newswire
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds

2026-02-10T08:00:00-05:00

PR Newswire
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™

2026-02-09T08:00:00-05:00

PR Newswire
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

2026-02-04T08:00:00-05:00

PR Newswire
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer

2026-01-07T07:00:00-05:00

PR Newswire
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

2025-12-30T07:00:00-05:00

PR Newswire
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development